Besides, SOX9 expression levels are related with chemoresistance in gastric, pancreatic, and colorectal cancer and high expression of SOX9 in several solid tumors is related to poor overall survival, biochemical recurrence-free survival, disease-specific survival, and DFS. Here, SOX9 is linked to colorectal cancer.